Chemomab Therapeutics Ltd. (CMMB)

1.75 -0.11 (-5.91%) USD  |  NASDAQ  |  Jun 02, 16:00
1.75 0.00 (0.00%) After-Hours: 19:21
More

Chemomab Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CMMB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
BioLineRx Ltd. Upgrade
Kamada Ltd. Upgrade
Can-Fite BioPharma Ltd. Upgrade
Galmed Pharmaceuticals Ltd. Upgrade
Entera Bio Ltd. Upgrade